LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Industry

EuroMedLab-WorldLab 2023 saw close to 12,000 attendees with more than 4000 delegates from 114 nations and over 4000 visitors (Photo courtesy of MZ Events)

WorldLab-EuroMedLab 2023 Technical Exhibition: Review of Innovations

The 25th International Congress of Clinical Chemistry and Laboratory Medicine (WorldLab) and 25th European Congress of Clinical Chemistry and Laboratory Medicine (EuroMedLab) were hosted by the Italian Society of Clinical Biochemistry and Clinical Molecular Biology on the occasion of their 55th Annual Congress, at the new Rome Convention Center “The Cloud” from May 21st to 25th, 2023. More...
19 Jun 2023
Image: The Seegene All-in-One Platform is a unique streamlined automation system (Photo courtesy of Seegene)

Seegene and Werfen to Jointly Develop Syndromic qPCR Assays

Seegene has entered into discussions with Werfen to expand their ongoing collaboration within the Spanish and Portuguese markets through Seegene's OneSystem Business. More...
15 Jun 2023
Image: The global HbA1c testing devices market is expected to reach USD 2.56 billion in 2027 (Photo courtesy of Freepik)

Global Hemoglobin A1c Testing Devices Market Driven by Rising Prevalence of Diabetes

The global HbA1c testing devices market is projected to expand at a CAGR of 10.3%, from USD 1.72 billion in 2023 to USD 2.56 billion in 2027, driven mainly by the rising prevalence of diabetes and other lifestyle diseases. More...
06 Jun 2023
Image: The Coris acquisition provides Avacta with a broad, professional-use rapid test product portfolio (Photo courtesy of Coris Bioconcept)

Avacta Expands Diagnostics Portfolio with Acquisition of Rapid Test Maker Coris Bioconcept

Avacta Group has acquired Coris Bioconcept for an upfront cash consideration of GBP 7.4 million, including an earnout, contingent on future business performance, which could amount to up to GBP 3 million in cash. More...
05 Jun 2023
Image: The global hemostasis diagnostics market is expected to reach USD 3.95 billion by 2025 (Photo courtesy of Freepik)

Global Hemostasis Diagnostics Market Driven by Increase in Invasive Surgical Procedures

The global hemostasis diagnostics market is projected to grow from USD 2.28 billion in 2018 to USD 3.95 billion by 2025, driven by an increase in blood clotting disorders, growing awareness about these conditions, and rising healthcare spending. More...
25 May 2023
Image: The global market for infectious disease-based tests using biomarkers is projected to reach USD 20.7 billion in 2027 (Photo courtesy of Freepik)

Global Market for Biomarker-Based Infectious Disease Tests to Surpass USD 20 Billion in 2027

The global market for infectious disease tests that utilize biomarkers is anticipated to expand at a CAGR of 5.8% from USD 14.8 billion in 2021 to USD 20.7 billion in 2027. More...
16 May 2023
Image: HemoCell Specialized Lab Automation is a customizable and fully automated workcell for hemostasis testing (Photo courtesy of Werfen)

Werfen and Thermo Fisher Enter Into Worldwide Distributor Agreement for Hemostasis Testing Workcell

Werfen has entered into a new long-term, exclusive partnership agreement with Thermo Fisher to globally distribute the TCAutomation laboratory automation system, specifically tailored for hemostasis diagnostics More...
05 May 2023
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
8-Channel Pipette
SAPPHIRE 20–300 µL
Gel Cards
DG Gel Cards


LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.